Judy Ellen Garber is the director of the Center for Cancer Genetics and Prevention at the Dana–Farber Cancer Institute and a professor of medicine at Harvard Medical School. Garber previously served as president of the American Association for Cancer Research.[1]
Judy E. Garber | |
|---|---|
| Alma mater | |
| Scientific career | |
| Institutions | |
Garber's research focuses on DNA damage in breast cancer.[1]
Garber attended Yale School of Medicine, receiving her MD/MPH in 1981. She did her residency in internal medicine and fellowship in hematology at Brigham and Women's Hospital in Boston.[2]
Garber has been the president of the Center for Cancer Genetics and Prevention at Dana-Farber since 2010.[1] In 2011–2012, Garber served as president of the American Association for Cancer Research. She is a member of the National Cancer Advisory Board[3] and a co-scientific director of the Breast Cancer Research Foundation.[4]
Awards
edit- 2001 Elected to the American Society for Clinical Investigation[5]
- 2008 Statesman Award, American Society for Clinical Oncology
- 2013 Elected to the National Academy of Medicine.[3]
- 2013 Elected fellow of the AACR Academy
- 2017 Margaret L. Kripke Legend Award, MD Anderson Cancer Center
- 2017 AACR Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research
- 2018 Giants of Cancer Care, OncLive[1]
- 2019 ASCO - American Cancer Society Award and Lecture
References
edit- ^ a b c d "Judy E. Garber, MD, MPH". www.aacr.org. Retrieved 17 January 2019.
- ^ "Judy E. Garber, MD, MPH - Dana–Farber Cancer Institute | Boston, MA". www.dana-farber.org. Retrieved 17 January 2019.
- ^ a b "Judy E. Garber | Researcher". Breast Cancer Research Foundation. 18 June 2014. Retrieved 17 January 2019.
- ^ "Breast Cancer Research Foundation". Breast Cancer Research Foundation.
- ^ "The American Society for Clinical Investigation". Retrieved 17 January 2019.